Case report


A disfiguring and fatal case of mucormycosis after dexamethasone treatment for a COVID-19 infection

Cynthia Guerin MD, Addie Pederson BA, Tristin Chaudhury MS, Kenn Freedman MD, Coby Ray MD, MS

ABSTRACT

This case report describes a patient with uncontrolled type 2 diabetes mellitus who received steroids for an outpatient infection of COVID-19. The steroid course combined with his acute illness likely contributed to his development of extremely high blood sugar levels (790 mg/dL) and subsequent hyperosmolar hyperglycemic syndrome. In this compromised state, he contracted invasive mucormycosis of the right sinuses and right orbit. This fungal infection caused him to lose his eye and, later, his life. Prescribing systemic steroids has many potential risks. Providers must be careful to use them only when absolutely indicated, especially in patients who are vulnerable to complications, such as those with uncontrolled type 2 diabetes. This case is a grim example of the dangers that can occur with systemic steroid use.

Keywords: Mucormycosis, SARS-COV-2, Rhizopus, diabetic ketoacidosis, dexamethasone




Article citation: Guerin C, Pederson A, Chaudhury T, Freedman K, Ray C. A disfiguring and fatal case of mucormycosis after dexamethasone treatment for a COVID-19 infection. The Southwest Respiratory and Critical Care Chronicles 2023;11(47):42–46

From: Department of Ophthalmology (CG, AP, KF, CR), School of Medicine (TC) Texas Tech University Health Sciences Center, Lubbock, Texas

Submitted: 1/19/2023

Accepted: 3/16/2023

Conflicts of interest: none

This work is licensed under a Creative Commons

Attribution-ShareAlike 4.0 International License.